News

Previously, Dr Kelly has served for Boehringer Ingelheim for nearly 20 years, most recently as vice president of Chemistry. Boehringer Ingelheim, develops and manufactures biopharmaceuticals by offering the

Additionally, BMS and Otsuka Pharma have received a priority review designation from the FDA for the sNDA. Sprycel, an oral BCR-ABL inhibitor, is currently approved by the FDA

Biogen Idec and Swedish Orphan Biovitrum said that the Phase 1/2a study of rFIXFc in 14 previously-treated patients with severe hemophilia B (less-than or equal to 2 U/dL

Optimum Nutrition claimed that Fitness Fiber can also be used to fortify the fiber potential of applesauce, cottage cheese, salad dressings, sauces, practically any food or beverage that

Cladribine is a small molecule that may interfere with the behavior and the proliferation of certain white blood cells, particularly lymphocytes, which are thought to be involved in

As per the terms of the contract, Immunotope and Midatech are expected to license specific intellectual property to Syntara for the development of immunotherapy products. Under the contract,

Earlier, in 2008 Signum and Rohto formed a strategic alliance for the development and commercialisation of skin care products in Japan. Under the contract, Rohto gained semi-exclusive rights

Axxess Pharma is expecting to sign the exclusive license agreement within next 2 weeks. The capsule is currently being sold by physicians, pharmacists and specialists in the US,

David Howson, president of Accelr8, said: “We are very pleased to have a diagnostics innovator select OptiChem after comparing a number of competing coatings. Once again, OptiChem offered